Replies to post #94793 on Amarantus Bioscience Holdings Inc (AMBS)

[Skeetz99]

Gerald has been somewhat quiet when it comes to releasing news/updates on LymPro. But when you can stand in front of an investor audience at a Conference; and confirm that you dont need to partner anytime soon (what a vote of confidence there).

In relation to the selloff, you only need to look at the chart and reconfirm the PPS is still in a very bullish formation. Lastly, Wall street had a risk off approach and trade over the last week or two (now, it appears the market correct is over; therefore, you can expect the risk on trade to be back and already started).

Bottome line: We are ripe for take off now; the only MAJOR missing link is cash....and my money says Gerald will get it done. GLTA!!!

[JLM27]

Great observation. I hope GC discusses the results on Monday.

[JPetroInc]

would not be all surprised to see the last tranche warrants cancelled/or renegotiated (at the very least)

always exciting - on the edge of your seat

[JPetroInc]

A little history on NuroPro and RBCC

Amarantus Biosciences and RBCC Announce NuroPro Parkinson's Diagnostic as Target for Joint Venture

08/10/12

"The companies expect to initiate Phase 2 clinical studies in 2013. It is expected that upon completing Phase 2, NuroPro would begin generating revenue through sales under the Clinical Laboratory Improvement Amendment (CLIA) certification."

http://bourse.challenges.fr/news.hts?menu=news_communiques&urlAction=news.hts?menu%3Dnews_communiques&idnews=BNW121008_00005518&numligne=41&date=121008&source=BNW